ARDT vs JCI · P/E 8.5, rev $6.32B vs P/E 44, rev $23.60B
Ardent Health Partners, Inc. (ARDT) versus Johnson Controls International PLC (JCI) — a side-by-side from cached financials, not a winner call.
Ardent Health Partners, Inc. (ARDT) is a medical care facilities company listed on US.
Johnson Controls International PLC (JCI) is a building products & equipment company listed on NYSE.
Latest reported ARDT revenue for 2025-12-31 was $6.32B. Net income was $135.8M. Revenue was up 6.0% from 2024-12-31 to 2025-12-31. ARDT currently screens at market cap $2.10B and trailing P/E 8.5.
Latest reported JCI revenue for 2025-09-30 was $23.60B. Net income was $3.51B. JCI currently screens at market cap $87.62B and trailing P/E 43.9.
ARDT currently screens at market cap $2.10B and trailing P/E 8.5. JCI currently screens at market cap $87.62B and trailing P/E 43.9.
Not investment advice. Open the ARDT and JCI stock pages for the full models.
Not investment advice.